seed
Stage
2023
Founded
1
Investors
About
Humane Genomics develops a novel class of oncolytic viruses for the targeted treatment of solid tumors. Their proprietary platform enables the rapid design and development of highly potent and safe viral therapies.
Explore Humane Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.